Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-23

Clinical Trial Update: The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing Haemodialysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy of niacin for hyperphosphatemia in patients undergoing haemodialysis. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Niacin (nicotinic acid)

Snippet

Sponsor: Assiut University | Conditions: Hyperphosphatemia | Phase 4 | Status: UNKNOWN